Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection

方法学和生物学变异对癌症检测中细胞外囊泡分子谱的影响

基本信息

  • 批准号:
    10115636
  • 负责人:
  • 金额:
    $ 68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-03-15 至 2023-02-28
  • 项目状态:
    已结题

项目摘要

Project Summary A novel paradigm in paracrine signaling has recently emerged based on the findings identifying extracellular vesicles (EVs) as intercellular conveyors of biological information both in normal and pathological conditions such as cancer. EVs and their cargo have been shown by us and others to regulate gene expression and alter cell function in various cell types. Moreover, during pathological conditions such as cancer, the number and compositions of EVs alter the host immune response as well as synchronize the behavior of secondary tumors. Isolation and molecular profiling of EVs (i.e. RNAs, proteins, post-translational modifications, lipids, metabolites) both in health and disease are critical for understanding EVs' biogenesis and effector functions. Currently, the study of EVs as biological entities relevant for intracellular signaling and disease diagnosis is based on the assumption that the biogenesis and removal of EVs happen at a steady state rate, being modified mostly by the healthy/diseased status of the host. Our published results show that that is not the case. Our data indicate that the tissue-origin, number, size distribution, as well as protein, lipid, metabolite and RNA composition of EVs isolated by standard techniques depend not just on the blood collection methods, but also on the time of the day the blood samples were collected. Therefore, systematic assessment of these factors and other sources of variability in EV profiles are important for enabling basic biology, clinical and personalized medicine applications. Although it is beyond the purpose of this grant, the long-term goal of our team is to establish reproducible methods for blood collection and sample processing that would allow us to identify the specific molecular EV signatures during the day/night cycle, with the aim of pinpointing the ideal, organ-specific times for blood collection, which would increase the reliability and specificity of early cancer detection. We believe that establishing biological and methodological baselines are absolutely vital for correctly comparing proteomics and glycomics data obtained in various studies, as well as interpreting the data obtained from patients' samples.
项目概要 基于识别细胞外信号的发现,最近出现了一种旁分泌信号传导的新范例 囊泡(EV)作为正常和病理条件下生物信息的细胞间传递者 例如癌症。我们和其他人已经证明电动汽车及其货物可以调节基因表达并改变 各种细胞类型的细胞功能。此外,在癌症等病理状况下,数量和 EV 的成分改变宿主免疫反应并同步继发性肿瘤的行为。 EV 的分离和分子分析(即 RNA、蛋白质、翻译后修饰、脂质、 代谢物)在健康和疾病中对于理解 EV 的生物发生和效应器功能至关重要。 目前,EVs作为与细胞内信号传导和疾病诊断相关的生物实体的研究正在进行中。 基于 EV 的生物发生和去除以稳态速率发生的假设, 主要由宿主的健康/患病状态改变。我们发表的结果表明,这不是 案件。我们的数据表明,组织来源、数量、大小分布,以及蛋白质、脂质、代谢物和 通过标准技术分离的 EV 的 RNA 组成不仅取决于血液采集方法,还取决于 也在一天中的某个时间采集血液样本。因此,系统地评估这些 EV 特征中的因素和其他变异来源对于实现基础生物学、临床和 个性化医疗应用。 虽然这超出了本次资助的目的,但我们团队的长期目标是建立可重复的 血液采集和样品处理方法使我们能够识别特定的分子 EV 昼/夜周期中的特征,目的是确定理想的、特定于器官的血液时间 收集,这将提高早期癌症检测的可靠性和特异性。我们相信 建立生物学和方法学基线对于正确比较蛋白质组学绝对至关重要 和在各种研究中获得的糖组学数据,以及解释从患者获得的数据 样品。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IONITA Calin GHIRAN其他文献

IONITA Calin GHIRAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IONITA Calin GHIRAN', 18)}}的其他基金

Red Blood Cells shuttle beta amyloid between brain and heart: implications for the pathogenesis and the progression of Alzheimer's and Cardiomyopathy
红细胞在大脑和心脏之间穿梭β淀粉样蛋白:对阿尔茨海默病和心肌病的发病机制和进展的影响
  • 批准号:
    10544297
  • 财政年份:
    2021
  • 资助金额:
    $ 68万
  • 项目类别:
Red Blood Cells shuttle beta amyloid between brain and heart: implications for the pathogenesis and the progression of Alzheimer's and Cardiomyopathy
红细胞在大脑和心脏之间穿梭β淀粉样蛋白:对阿尔茨海默病和心肌病的发病机制和进展的影响
  • 批准号:
    10319189
  • 财政年份:
    2021
  • 资助金额:
    $ 68万
  • 项目类别:
Integrative, multi-parametric characterization of the EV surface protein and nucleic acid landscape by nano-flow and sorting cytometry
通过纳流和分选细胞术对 EV 表面蛋白和核酸景观进行综合、多参数表征
  • 批准号:
    9811821
  • 财政年份:
    2019
  • 资助金额:
    $ 68万
  • 项目类别:
Integrative, multi-parametric characterization of the EV surface protein and nucleic acid landscape by nano-flow and sorting cytometry
通过纳流和分选细胞术对 EV 表面蛋白和核酸景观进行综合、多参数表征
  • 批准号:
    10350018
  • 财政年份:
    2019
  • 资助金额:
    $ 68万
  • 项目类别:
Integrative, multi-parametric characterization of the EV surface protein and nucleic acid landscape by nano-flow and sorting cytometry
通过纳流和分选细胞术对 EV 表面蛋白和核酸景观进行综合、多参数表征
  • 批准号:
    10018937
  • 财政年份:
    2019
  • 资助金额:
    $ 68万
  • 项目类别:
Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection
方法学和生物学变异对癌症检测中细胞外囊泡分子谱的影响
  • 批准号:
    10509911
  • 财政年份:
    2018
  • 资助金额:
    $ 68万
  • 项目类别:
Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection
方法学和生物学变异对癌症检测中细胞外囊泡分子谱的影响
  • 批准号:
    10373959
  • 财政年份:
    2018
  • 资助金额:
    $ 68万
  • 项目类别:
Impact of circadian rhythm in obtaining reference profiles of exRNAs in healthy i
昼夜节律对获取健康人 exRNA 参考谱的影响
  • 批准号:
    9058134
  • 财政年份:
    2014
  • 资助金额:
    $ 68万
  • 项目类别:
Malaria screening in resource-poor settings using a simple, power-free, cell phone-friendly device
使用简单、无电源、适合手机使用的设备在资源匮乏的环境中进行疟疾筛查
  • 批准号:
    8925940
  • 财政年份:
    2014
  • 资助金额:
    $ 68万
  • 项目类别:
Impact of circadian rhythm in obtaining reference profiles of exRNAs in healthy i
昼夜节律对获取健康人 exRNA 参考谱的影响
  • 批准号:
    8897443
  • 财政年份:
    2014
  • 资助金额:
    $ 68万
  • 项目类别:

相似海外基金

EPIphANy (Evaluation of Pharmacological Interactions with Anticoagulants in caNcer patients) program - prostate cancer cohort
EPIPHANy(癌症患者抗凝药理相互作用的评估)计划 - 前列腺癌队列
  • 批准号:
    479295
  • 财政年份:
    2023
  • 资助金额:
    $ 68万
  • 项目类别:
    Operating Grants
Inhibitors of Human Factor XIIIa as New Anticoagulants
人类因子 XIIIa 抑制剂作为新型抗凝剂
  • 批准号:
    10629057
  • 财政年份:
    2023
  • 资助金额:
    $ 68万
  • 项目类别:
Establishment of comprehensive monitoring of direct oral anticoagulants (DOACs) for clinical application
建立临床应用直接口服抗凝剂(DOAC)综合监测体系
  • 批准号:
    23K06906
  • 财政年份:
    2023
  • 资助金额:
    $ 68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Interactions of Enzyme-Inducing Antiepileptic Drugs with Direct-Acting Oral Anticoagulants: Risk of Thromboembolic Events
酶诱导抗癫痫药物与直接作用口服抗凝剂的相互作用:血栓栓塞事件的风险
  • 批准号:
    10605482
  • 财政年份:
    2023
  • 资助金额:
    $ 68万
  • 项目类别:
The Comparative Effectiveness and Safety of Oral Anticoagulants in Patients with Cirrhosis and Atrial Fibrillation
口服抗凝药对肝硬化合并心房颤动患者的有效性和安全性比较
  • 批准号:
    10559071
  • 财政年份:
    2023
  • 资助金额:
    $ 68万
  • 项目类别:
Search for indicators of blood levels of directly inhibitory oral anticoagulants in coagulation tests using artificial intelligence
使用人工智能在凝血测试中搜索直接抑制性口服抗凝剂的血液水平指标
  • 批准号:
    22K07388
  • 财政年份:
    2022
  • 资助金额:
    $ 68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Bleeding on Direct Oral Anticoagulants: Identification of Genetic Risk Factors and a Polygenic Predictive Score in Patients with Atrial Fibrillation
直接口服抗凝剂导致的出血:房颤患者遗传风险因素的鉴定和多基因预测评分
  • 批准号:
    10536789
  • 财政年份:
    2022
  • 资助金额:
    $ 68万
  • 项目类别:
Study on proper use of oral anticoagulants combined with 5-fluorouracil
口服抗凝药联合5-氟尿嘧啶正确使用研究
  • 批准号:
    22K06743
  • 财政年份:
    2022
  • 资助金额:
    $ 68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Benchmarking a point-of-care test kit for detection of direct-oral anticoagulants
用于检测直接口服抗凝剂的即时检测试剂盒的基准测试
  • 批准号:
    461790
  • 财政年份:
    2022
  • 资助金额:
    $ 68万
  • 项目类别:
    Operating Grants
Direct oral anticoagulants and the risk of colorectal and pancreatic cancers: a population-based cohort study.
直接口服抗凝剂与结直肠癌和胰腺癌的风险:一项基于人群的队列研究。
  • 批准号:
    474475
  • 财政年份:
    2022
  • 资助金额:
    $ 68万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了